4//SEC Filing
Martin Tami Tillotson 4
Accession 0001104659-23-096582
CIK 0001356576other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 5:00 PM ET
Size
5.5 KB
Accession
0001104659-23-096582
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Sale
Common Stock
2023-08-25$31.59/sh−5,135$162,215→ 85,249 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.38 to $31.92, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Includes an aggregate of 350 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001539494
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 5:00 PM ET
- Size
- 5.5 KB